Syber-LS
Syber-LS is an advanced gastrointestinal formulation combining Rabeprazole Sodium (EC) & Levosulpiride (SR) Capsules. This dual-action medication is designed to treat severe acid reflux (GERD), irritable bowel syndrome, and functional dyspepsia by combining a potent acid reducer with a digestive motility enhancer.
Description
Syber-LS offers a comprehensive solution for complex digestive disorders. While standard acidity medicines only stop acid production, Syber-LS also addresses the underlying motility issues that cause bloating, heaviness, and reflux.
Key Therapeutic Benefits:
-
Fast-Acting Acid Suppression: Rabeprazole Sodium (Enteric Coated) provides rapid relief from heartburn and protects the esophagus by inhibiting the proton pump in the stomach.
-
Enhanced Gastric Motility: Levosulpiride (Sustained Release) helps the stomach empty faster, preventing food from staying too long and causing gas, bloating, or acid backflow.
-
GERD & IBS Management: Highly effective for Gastroesophageal Reflux Disease (GERD) that doesn’t respond to standard PPIs, as well as symptoms of Irritable Bowel Syndrome (IBS).
-
Sustained Release Technology: The “SR” (Sustained Release) component ensures the medication works throughout the day, providing consistent relief from nausea and abdominal discomfort.
-
Enteric Coated for Safety: The “EC” coating ensures the Rabeprazole passes through the stomach safely and is absorbed in the intestine for maximum effectiveness without irritation.
Core Composition:
-
Rabeprazole Sodium IP: $20 \text{ mg}$ (Enteric Coated)
-
Levosulpiride IP: $75 \text{ mg}$ (Sustained Release)
Usage & Safety Guidelines
-
Indication: GERD, Diabetic Gastroparesis, Functional Dyspepsia, and Chronic Gastritis.
-
Dosage: Usually one capsule daily, taken in the morning on an empty stomach (30 minutes before breakfast), or as directed by your physician.
-
Storage: Store in a cool, dry, and dark place. Protect from direct heat and moisture.
